Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
200.00
+0.87 (0.44%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts that cover Tenet Healthcare stock have a consensus rating of "Buy" and an average price target of $205.39, which forecasts a 2.69% increase in the stock price over the next year. The lowest target is $154 and the highest is $238.
Price Target: $205.39 (+2.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 10 | 9 | 10 | 10 | 10 | 10 |
| Hold | 2 | 2 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 18 | 18 | 18 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $194 → $225 | Buy | Maintains | $194 → $225 | +12.50% | Oct 17, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $224 | Strong Buy | Initiates | $224 | +12.00% | Oct 14, 2025 |
| Keybanc | Keybanc | Buy Maintains $205 → $225 | Buy | Maintains | $205 → $225 | +12.50% | Oct 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $200 → $238 | Buy | Maintains | $200 → $238 | +19.00% | Oct 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $190 | Buy | Reiterates | $190 | -5.00% | Oct 7, 2025 |
Financial Forecast
Revenue This Year
21.34B
from 20.67B
Increased by 3.29%
Revenue Next Year
22.26B
from 21.34B
Increased by 4.28%
EPS This Year
15.82
from 32.70
Decreased by -51.64%
EPS Next Year
16.26
from 15.82
Increased by 2.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.5B | 23.6B | |||
| Avg | 21.3B | 22.3B | |||
| Low | 20.5B | 21.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.8% | 10.6% | |||
| Avg | 3.3% | 4.3% | |||
| Low | -0.8% | -1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.15 | 18.70 | |||
| Avg | 15.82 | 16.26 | |||
| Low | 12.32 | 13.24 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -47.5% | 18.3% | |||
| Avg | -51.6% | 2.8% | |||
| Low | -62.3% | -16.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.